The present invention discloses the isolation of the human and murine
wild-type Int6 gene and the cDNAs sorresponding to these genes. The
invention further describes the use of reagents derived from the nucleic
acid and amino acid sequences of the Int6 gene in diagnostic methods,
immunotherapy, gene therapy and as vaccines.